MedPath

SMaRT Mom - Smartphone Management and Responsive Time for Breastfeeding Mothers

Not Applicable
Recruiting
Conditions
Smartphone Addiction
Breastfeeding
Infant Behavior
Mother-Infant Interaction
Interventions
Behavioral: SMaRT Mom
Registration Number
NCT06030830
Lead Sponsor
Bar-Ilan University, Israel
Brief Summary

In the last decade, infants are born into a social environment in which the smartphone has become an essential part of our lives. Smartphone use draws the mother's attention during mother-infant interactions and thus may affect the infant development as well as maternal self-efficacy. However, the effects of smartphone use reduction among breastfeeding mothers during their interactions with their infants have not been studied yet. In the present study, we propose to evaluate a "SMaRT Mom" intervention that we have developed, to manage and reduce smartphone use during breastfeeding. The purpose of the study is to evaluate the effects of the SMaRT Mom intervention on breastfeeding mothers' biobehavioral mechanisms, self-efficacy and the socioemotional characteristics of their infants. This will extend our knowledge of the peculiarities of early mother-infant interactions in the digital era, when smartphones play a critical role.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • 3-6 months old infant
  • Smartphone Addiction Scale' cut-off (31 and above)
Exclusion Criteria
  • No neurological disorders
  • No heart disease
  • No anxiety and depression
  • No use of psychiatric drugs

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InterventionSMaRT MomParticipants will be instructed not to use the smartphone during breastfeeding for a week
Primary Outcome Measures
NameTimeMethod
Infant temperamentPre (day 1) and post (day 8) lab visit (before and after intervention/control week)

Infants' temperament will be reported by breastfeeding mothers before and after the intervention week using the Infant Behavior Questionnaire - Revised - Very Short Form (IBQ-rvsf). Scale scores represent the mean score of all scale items applicable to the child, as judged by the caregiver. 1. Sum all numerical item responses for a given scale. Note that: a) If caregiver omitted an item, that item receives no numerical score; b) If caregiver checked the "does not apply" response option for an item, that item receives no numerical score; 2. Divide the total by the number of items receiving a numerical response. Not including items marked "does not apply (N/A)" or items receiving no response in determining the number of items. The surgency, negative affect and effortful control subscales' items will be averaged

Maternal self-efficacyPre (day 1) and post (day 8) lab visit (before and after intervention/control week)

Maternal self-efficacy questionnaire (MSQ) will be self-reported by breastfeeding mothers before and after the intervention week.

The scale applies a special method to measure maternal self-efficacy and mostly focuses on a mother's infant care responsibilities.

The scale consists of 10 items.Higher score indicates higher maternal self-efficacy

Secondary Outcome Measures
NameTimeMethod
Self-reported maternal attention towards infantPre (day 1) and post (day 8, day 14, day 30) lab visit after intervention/control week

Maternal attention towards the infant will be self-reported by mothers before and after the intervention week ("How attentive do you feel towards your infant during breastfeeding?")

Breastfeeding as a rewarding experiencePre (day 1) and post (day 8, day 14, day 30) lab visit after intervention/control week

The rewarding experience of breastfeeding will be self-reported by mothers before and after the intervention week ("How rewarding is the experience of breastfeeding for you?")

Changes in breastfeeding mothers' physiological responses - HRVday 1 and day 8 during lab visits

Heart Rate Variability (HRV) will be measured via The MindWare Mobile Recorder (MindWare Technologies, Inc., Gahanna, OH), a well-validated and specialized hardware and software system that is aimed at monitoring autonomic balance, cardiac performance, respiratory measurements and activity. Participants are each will be fitted with a MindWare Mobile device and specialized electrodes to measure the electrocardiogram (allows to derive HRV), Z0, dz/dt (allows to assess respiration and cardiology impedance) and SCL (allows to derive electrodermal activity from the skin) (for similar method see Nomkin \& Gordon, 2021).

Changes in breastfeeding mothers' physiological responses - Cardiograph Impedanceday 1 and day 8 during lab visits

Cardiograph Impedance will be measured via The MindWare Mobile Recorder (MindWare Technologies, Inc., Gahanna, OH), a well-validated and specialized hardware and software system that is aimed at monitoring autonomic balance, cardiac performance, respiratory measurements and activity. Participants are each will be fitted with a MindWare Mobile device and specialized electrodes to measure the electrocardiogram (allows to derive HRV), Z0, dz/dt (allows to assess respiration and cardiology impedance) and SCL (allows to derive electrodermal activity from the skin) (for similar method see Nomkin \& Gordon, 2021).

Changes in breastfeeding mothers' neural activity - ERPday 1 and day 8 during lab visits

Event related response during the smartphone cue-reactivity task, attentional bias is indicated by an enhancement in the late positive potential (LPP), which is strongly evoked by emotionally salient stimuli. The LPP is maximum over central-parietal regions occurring between 300 and 700 ms following an emotional stimulus

Changes in breastfeeding mothers' physiological responses - Electrodermal activityday 1 and day 8 during lab visits

Skin Conductance Level (SCL) will be measured via The MindWare Mobile Recorder (MindWare Technologies, Inc., Gahanna, OH), a well-validated and specialized hardware and software system that is aimed at monitoring autonomic balance, cardiac performance, respiratory measurements and activity. Participants are each will be fitted with a MindWare Mobile device and specialized electrodes to measure the electrocardiogram (allows to derive HRV), Z0, dz/dt (allows to assess respiration and cardiology impedance) and SCL (allows to derive electrodermal activity from the skin) (for similar method see Nomkin \& Gordon, 2021).

Video recorded maternal attention towards infantday 1 and day 8 during lab visits

Maternal attention towards the infant will be video recorded during both laboratory sessions

Changes in breastfeeding mothers' neural activity - Frontal asymmetryday 1 and day 8 during lab visits

Frontal asymmetry during maternal baseline, breastfeeding and mother-infant face-to-face interaction EEG data will be acquired from breastfeeding mothers' heads using Enobio8 device with eight electrodes from the frontal, and central-parietal areas - Fp1, Fp2, F3, F4, F7, F8, P3 and P4 and voltage fluctuations in the alpha frequency band will be measured between pairs of electrodes that will be produced by the excitation of neuronal synapses.

Trial Locations

Locations (1)

Gonda Brain Center, Bar-Ilan University

🇮🇱

Ramat Gan, Israel

© Copyright 2025. All Rights Reserved by MedPath